logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
Breast Cancer cover

Breast Cancer

IF2.9
Papers2262
Citations3595
Journal Papers 2255
Publication Date
delete
Target trial emulation of first-line ribociclib versus palbociclib in hormone receptor-positive, HER2-negative metastatic breast cancer: a comparative effectiveness study
deleteBreast Cancer
IF2.9
delete2026-10-06
delete0
PREAI
deleteXiaoyi Zhang; Po-Huang Chen; Wei-Cheng Chang; Hong-Jie Jhou; Hsin-Yu Chen; Li-Ting Kao; Tina Yi-Jin Hsieh; Ming-Shen Dai; Na Xiao; Cho-Hao Lee
deleteShare
deleteSave
Preoperative CA15-3 as a predictor of axillary lymph node metastasis and prognosis in women with breast cancer: a GRADE-assessed systematic review and meta-analysis
deleteBreast Cancer
IF2.9
delete2026-10-05
delete0
PREAI
deleteMansour Bahardoust; Anita Rezaei; Anahita Hosseinali; Golnaz Ranjbarpazuki; Sajad Salehi; Meisam Haghmoradi; Shoboo Rahmati; Nahid Nafissi
deleteShare
deleteSave
Effects of exercise and educational programs on long-term quality of life, anxiety, and depression in breast cancer survivors: an exploratory secondary analysis of the Setouchi breast project-10 randomized controlled trial
deleteBreast Cancer
IF2.9
delete2026-10-03
delete0
PREAI
deleteAzusa Jo; Takayuki Iwamoto; Kengo Kawada; Youko Suzuki; Kyoko Hara; Seiji Yoshitomi; Daisuke Takabatake; Shinichiro Kubo; Yutaka Ogasawara; Shozo Ohsumi; Masahiko Ikeda; Hiroyoshi Doihara; Yuri Mizota; Seiichiro Yamamoto; Naruto Taira
deleteShare
deleteSave
Long-term outcomes of invasive lobular carcinoma compared with invasive ductal carcinoma in HR-positive/HER2-negative breast cancer: a focus on luminal subtypes
deleteBreast Cancer
IF2.9
delete2026-10-03
delete0
PREAI
deleteSayoko Kakimoto; Hiroyuki Yamamoto; Junki Koike; Koichiro Tsugawa
deleteShare
deleteSave
Mindful eating as a supportive intervention for breast cancer survivors: a pilot randomized controlled trial
deleteBreast Cancer
IF2.9
delete2026-09-27
delete0
deleteOAAI
deleteDilşat Baş; Gizem Ağır; Özlem Sönmez; Ece Öneş
deleteShare
deleteSave
Clinical impact of ENIGMA-based variant reclassification on genotype–phenotype analyses in BRCA1- and BRCA2-associated hereditary breast and ovarian cancer
deleteBreast Cancer
IF2.9
delete2026-09-25
delete0
PREAI
deleteSaid Furkan Yildirim; Pervin Demir; Hakan Kosku; Bulent Yalcin; Ahmet Cevdet Ceylan
deleteShare
deleteSave
Triggering receptors expressed on myeloid cells (TREM-1) and TREM-2 as predictors of pathological complete response to neoadjuvant therapy in triple-negative breast cancer
deleteBreast Cancer
IF2.9
delete2026-09-21
delete0
deleteOAAI
deleteNazan Demir; İvo Gökmen; Duygu Bayır Garbioğlu; Ebru Taştekin; Emre Işık; Erkan Özcan; Bülent Erdoğan; Sernaz Topaloğlu; Bahadır Köylü; Cevat İlteriş Kıkılı; Fatih Kemik; İrfan Çiçin; Fatih Selçukbiricik; Muhammet Bekir Hacıoğlu
deleteShare
deleteSave
Five-year outcomes of partial breast proton beam therapy without lumpectomy for early-stage breast cancer: an interventional prospective study
deleteBreast Cancer
IF2.9
delete2026-09-19
delete0
PREAI
deleteEtsuyo Ogo; Takeshi Arimura; Takashi Ogino; Uhi Toh; Kenta Murotani; Ichiro Isomoto; Makoto Kubo; Reiki Nishimura; Yusaku Miyata; Gen Suzuki; Yoshio Hishikawa; Shoshu Mitsuyama; Ryoichi Nagata
deleteShare
deleteSave
Pathologic complete response and survival according to germline BRCA1/2 status in triple-negative breast cancer
deleteBreast Cancer
IF2.9
delete2026-09-10
delete0
deleteOAAI
deletePaulina Gebhart; Florian Heinzl; Chiara Kahl; Alev Bari; Georg Langs; Daniela Muhr; Christian F. Singer; Yen Y. Tan
deleteShare
deleteSave
Correction: Initial activities and prospects of MIRAY1: a youth-driven, society-endorsed initiative to cultivate future breast cancer physicians
deleteBreast Cancer
IF2.9
delete2026-09-06
delete0
PREAI
deleteHiroko Masuda; Takaaki Konishi; Mai Onishi; Aki Ito; Kazunoshin Tachibana; Akari Murakami; Atsushi Fushimi; Ryota Otsubo; Haruru Kotani; Yuri Kimura; Yuka Inoue; Yukinori Ozaki; Kaori Tane; Tsutomu Iwasa; Yuko Takahashi; Yuko Kanemoto; Yurika Iida; Chiaki Kudo; Sayuka Nakayama; Takahiro Suzuki; Midori Morita; Riko Sato; Masafumi Iida; Akihiko Ozaki; Mai Kitazawa; Mio Adachi; Masafumi Inokuchi; Chikako Yamauchi; Takanori Ishida; Norikazu Masuda; Masakazu Toi
deleteShare
deleteSave
Exercise prehabilitation in breast cancer surgery: are we measuring the right outcomes?
deleteBreast Cancer
IF2.9
delete2026-09-03
delete0
PREAI
deleteKadri Altundag
deleteShare
deleteSave
Association between preoperative body composition and health-related quality of life in breast cancer patients: a prospective Eastern European study
deleteBreast Cancer
IF2.9
delete2026-09-03
delete0
deleteOAAI
deleteKatarzyna Mielniczek; Radosław Mlak; Aleksandra Kowalska; Katarzyna Jóźwik; Karol Rawicz-Pruszyński; Zuzanna Pelc
deleteShare
deleteSave
Correction: Prognostic model based on six PD‑1 expression and immune infiltration‑associated genes predicts survival in breast cancer
deleteBreast Cancer
IF2.9
delete2026-09-03
delete0
PREAI
deleteShen Junjun; Zhuang Jing; Pu Jie; Chu Jian; Pan Yuefen; Han Shuwen
deleteShare
deleteSave
Real-world outcomes of datopotamab deruxtecan after trastuzumab deruxtecan in hormone receptor–positive, HER2-negative metastatic breast cancer
deleteBreast Cancer
IF2.9
delete2026-09-02
delete0
deleteOAAI
deleteYosuke Aoyama; Yukinori Ozaki; Masahiro Kuno; Rika Kizawa; Jun Masuda; Meiko Nishimura; Mami Kurata; Lina Inagaki; Mari Hosonaga; Ippei Fukada; Tetsuyo Maeda; Kazuyo Yoshida; Nami Yamashita; Takayuki Kobayashi; Toshimi Takano; Takayuki Ueno
deleteShare
deleteSave
Publisher Correction: PTX3 induces the expression of PD-L1 and promotes breast cancer immune escape
deleteBreast Cancer
IF2.9
delete2026-09-01
delete0
PREAI
deleteLiyuan Jing; Jie Lun; Jianxin Xu; Zhengyu Jin; Xingqian Liu; Yu Wang; Yuying Zhang; Min Gao; Mengchao Yu; Hongwei Zhang; Jing Fang
deleteShare
deleteSave
The value of LAR in predicting neoadjuvant therapy response and prognosis in HER2-positive breast cancer
deleteBreast Cancer
IF2.9
delete2026-08-24
delete0
PREAI
deleteXiaojing Li; Xin Xin; Wenjing Xiong; Haoyue Zhang; Yue Zhang
deleteShare
deleteSave
Correction: Cost-effectiveness analysis of the Oncotype DX Breast Recurrence Score® test among node-negative early breast cancer patients in Japan
deleteBreast Cancer
IF2.9
delete2026-08-21
delete0
deleteOAAI
deleteKei Koizumi; Ataru Igarashi; Mark Gouldson; Sandeep Bilthare; Sebastien Eymere; Gebra Cuyún-Carter; Steve Millen; Mariko Nomoto; Yoshie Onishi; Aki Kudo; Pieter Drost; Naoko Sugiyama; Tom Kanazawa Tang; Naoki Niikura
deleteShare
deleteSave
Hormonal contraceptives and cancer risk in women with a BRCA1 or BRCA2 pathogenic variant
deleteBreast Cancer
IF2.9
delete2026-08-18
delete0
deleteOAAI
deleteChen Nahshon; Leen Fahoum; Dana Hadar; Hila Cohen; Rachel Michaelson-Cohen; Shira Regev; Meirav Schmidt; Wisam Assaf; Steven A. Narod; Yakir Segev
deleteShare
deleteSave
Risk of febrile neutropenia in breast cancer chemotherapy despite the prophylactic use of pegfilgrastim: a retrospective analysis
deleteBreast Cancer
IF2.9
delete2026-08-14
delete0
deleteOAAI
deleteHiroki Kusama; Yoshiya Horimoto; Kyoko Iwai; Yuki Kitaoku; Fujina Takeda; Ryo Hamaoka; Minami Iwai; Mizuki Mizuuchi; Tomoka Ushio; Kyoko Orimoto; Takashi Ishikawa
deleteShare
deleteSave
Next-generation endocrine therapy in HR+/HER2 − breast cancer: oral SERDs, ER-targeting innovations, and ctDNA-driven ESR1 mutation–guided switching
deleteBreast Cancer
IF2.9
delete2026-08-07
delete0
PREAI
deleteNan Yao; Guoshuai Xu; Ning Duan; Fuzhou Han; Wenqiang Li; Jun Qu
deleteShare
deleteSave